<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1'); </script>
Logo-bi
Bioimpacts. 2025;15: 30880 | Published on: 2025 Aug 20. doi: 10.34172/bi.30880
PMID: 40922955        PMCID: PMC12413979

Original Article

Allogeneic Treg-derived artificial vesicles: A promising therapeutic modality for multiple sclerosis

Irina Alekseevna Ganeeva 1 ORCID, Elvina Maratovna Gilyazova 1, Arthur Ajdarovich Khannanov 2, Mariia Eugenievna Nektorova 1, Alexey Michailovich Rogov 1, Timur Ildarovich Khaibullin 3, Ekaterina Anatolievna Zmievskaya 1 * ORCID, Emil Rafaelevich Bulatov 1,4

Cited by CrossRef: 0

1- Ren T, Shen Y, Li J, Zhang Z, Liu Z, Bao L, Li X. Integration of single-cell cis-expression quantitative trait locus and Mendelian randomization analyses identifies a Treg-specific gene for precision therapy in rheumatoid arthritis, gonarthrosis, and gouty arthritis. J Int Med Res. 2026;54(6) [Crossref]
2- Kırboğa K, Rudrapal M. Systems pharmacology approaches to modeling immune training and tolerance. Current Opinion in Pharmacology. 2026;89:102630 [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 19% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons